RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    건강할 권리와 치료의 정치: 태국 에이즈 감염인의 의약품 접근권 운동 = The Right to Health and Politics of Treatment: Access to Antiretroviral Drugs in Thailand

    한글로보기

    https://www.riss.kr/link?id=A82602901

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    This article presents an analysis of AIDS treatment activism formed by people living with HIV/AIDS (PLWHA); their demand is universal access to antiretroviral therapies (ARVS). When used successfully, ARVS prevent disease progression and improve the health of PLWHA. In Thailand, AIDS treatment activism mounted in the late 1990s to promote generic drug production and demand government support for AIDS treatment. This analysis draws from participant observations of AIDS-related NGO activities, especially focusing on the Thai Network for People Living with HIV/AIDS (TNP+). To secure PLWHA`s right to receive proper treatment in Thailand, the activists are pursuing a successive process to generate the institutional transformation of ARVS distribution. In the first stage, the breaking of multinational pharmaceutical company monopolies allows more extensive access to ARV. Thai AIDS activists brought lawsuits against the multinational drug company Bristol Myers-Squibb in 2001 to revoke a patent on didanosine, and the activists finally won the case in 2002. In the second stage of the process, the public healthcare system becomes a crucial channel for ARVS distribution. To make the implementation of AIDS treatment possible, two major factors are mainly considered by the activists and the state. One factor is the decrease in cost which occurred after the Government Pharmaceutical Organization started launching low-priced generic drugs. The other factor is the demonstration of cost-effectiveness of AIDS treatment. In addition, the representation of PLWHA as productive population is also accompanied. Since 2005, AIDS treatment has been freely dispensed via the universal health care scheme. In the third phase, to ensure the continuity of AIDS treatment, the state directly intervenes to adjust drug prices, and market intervention is aggressively supported by AIDS treatment activism. In 2007, the Thai government announced compulsory licensing for three drugs including 2nd line ARVS. Finally, AIDS treatment activism in Thailand transforms ARVS from a rare good into a public good. It illustrates that ARVS as a commodity should be governed not by ability to pay but by public interest. Corresponding to a processual resolution of the antagonism between private ownership and human rights, the transformative processes rearrange symbolic and legal hierarchy among rights. Furthermore, AIDS treatment activism in Thailand reveals how rights-based activist groups respond to demand distributional justice and provoke the state`s intervention over the market. It is a new form of social mobilization, which opens up a new line of inquiry into the study of struggles for public good in the globalizing world.
    번역하기

    This article presents an analysis of AIDS treatment activism formed by people living with HIV/AIDS (PLWHA); their demand is universal access to antiretroviral therapies (ARVS). When used successfully, ARVS prevent disease progression and improve the h...

    This article presents an analysis of AIDS treatment activism formed by people living with HIV/AIDS (PLWHA); their demand is universal access to antiretroviral therapies (ARVS). When used successfully, ARVS prevent disease progression and improve the health of PLWHA. In Thailand, AIDS treatment activism mounted in the late 1990s to promote generic drug production and demand government support for AIDS treatment. This analysis draws from participant observations of AIDS-related NGO activities, especially focusing on the Thai Network for People Living with HIV/AIDS (TNP+). To secure PLWHA`s right to receive proper treatment in Thailand, the activists are pursuing a successive process to generate the institutional transformation of ARVS distribution. In the first stage, the breaking of multinational pharmaceutical company monopolies allows more extensive access to ARV. Thai AIDS activists brought lawsuits against the multinational drug company Bristol Myers-Squibb in 2001 to revoke a patent on didanosine, and the activists finally won the case in 2002. In the second stage of the process, the public healthcare system becomes a crucial channel for ARVS distribution. To make the implementation of AIDS treatment possible, two major factors are mainly considered by the activists and the state. One factor is the decrease in cost which occurred after the Government Pharmaceutical Organization started launching low-priced generic drugs. The other factor is the demonstration of cost-effectiveness of AIDS treatment. In addition, the representation of PLWHA as productive population is also accompanied. Since 2005, AIDS treatment has been freely dispensed via the universal health care scheme. In the third phase, to ensure the continuity of AIDS treatment, the state directly intervenes to adjust drug prices, and market intervention is aggressively supported by AIDS treatment activism. In 2007, the Thai government announced compulsory licensing for three drugs including 2nd line ARVS. Finally, AIDS treatment activism in Thailand transforms ARVS from a rare good into a public good. It illustrates that ARVS as a commodity should be governed not by ability to pay but by public interest. Corresponding to a processual resolution of the antagonism between private ownership and human rights, the transformative processes rearrange symbolic and legal hierarchy among rights. Furthermore, AIDS treatment activism in Thailand reveals how rights-based activist groups respond to demand distributional justice and provoke the state`s intervention over the market. It is a new form of social mobilization, which opens up a new line of inquiry into the study of struggles for public good in the globalizing world.

    더보기

    참고문헌 (Reference)

    1 Bangkok Post,

    2 Financial Times,

    3 Nation,

    4 Nation,

    5 Wall Street Journal,

    6 안젤, 마르시아, "제약회사들은 어떻게 우리 주머니를 털었나" 청년의사 2007

    7 서보경, "에이즈 감염인의 의약품 접근권 운동" 서울대학교 2008

    8 하비, 데이비드, "신자유주의: 간략한 역사" 한울아카데미 2007

    9 Fordham, Graham, "Whisky, Women and Song: Men, Alcohol and AIDS in Northern Thailand" 6 (6): 154-177, 1995

    10 Medicines Sans Frontieres, "Untangling the Web of Price Reduction: A Pricing Guide for the Purchase of ARVs for Developing Countries (8th Edition), Geneva: MSF"

    1 Bangkok Post,

    2 Financial Times,

    3 Nation,

    4 Nation,

    5 Wall Street Journal,

    6 안젤, 마르시아, "제약회사들은 어떻게 우리 주머니를 털었나" 청년의사 2007

    7 서보경, "에이즈 감염인의 의약품 접근권 운동" 서울대학교 2008

    8 하비, 데이비드, "신자유주의: 간략한 역사" 한울아카데미 2007

    9 Fordham, Graham, "Whisky, Women and Song: Men, Alcohol and AIDS in Northern Thailand" 6 (6): 154-177, 1995

    10 Medicines Sans Frontieres, "Untangling the Web of Price Reduction: A Pricing Guide for the Purchase of ARVs for Developing Countries (8th Edition), Geneva: MSF"

    11 Chaudhuri, Sudip, "The WTO and India’s Pharmaceuticals Industry: Patent Protection, Trips, and Developing Countries" Oxford University Press 2005

    12 Petryna, Adriana, "The Parmaceutical Nexus, in : Global Pharmaceuticals" Duke University Press 1-32, 2006

    13 Chasombat, Sanchai, "The National Access to Antiretroviral Program for PHA(NAPHA) in Thailand" 37 (37): 704-715, 2006

    14 National Health Security Office (약칭 NHSO), "The Expansion of National ARV Access under the Universal Coverage Healthcare Scheme" NHSO 2007

    15 Revenga, Ana, "The Economics of Effective Aids Treatment: Evaluating Policy Options for Thailand" World Bank 2006

    16 World Bank, "Thailand Social Monitor: Thai Workers and the Crisis" World Bank 2000

    17 Ministry of Public Health (약칭 MOPH), "Public Health Stastics" MOPH 2003

    18 Thai Working Group on HIV/AIDS Projection, "Projections for HIV/AIDS in Thailand: 2000-2020, Nonthaburi: Division of AIDS, Department of Communicable Disease Control, Ministry of Public Health"

    19 Biehl, Joao, "Pharmaceutical Governance,”in : Global Pharmaceuticals: Ethics, Markets, Practices" Duke University Press 206-239, 2006

    20 Ariss, Robert, "Performing Anger: Emotion in Strategic Responses to Aids" 4 (4): 18-30, 1993

    21 Muecke, Marjorie, "Mother Sold Food, Daughter Sells Her Body: The Cultural Continuity of Prostitution" 35 (35): 891-901, 1992

    22 Michinobu, Ryoko, "Lives in Transition: The Influence of Northern Thailand’s Economic and Cultural Change on Young Factory Women’s Sexual Behavior and HIV Risk, Nakornpathom: Center for Health Policy Studies"

    23 Gould, Deborah B., "Life during Wartime: Emotions and the Development of Act Up" An International Quarterly 177-200, 2002

    24 Petryna, Adriana, "Life Exposed: Biological Citizens after Chernobyl" Princeton University Press 2002

    25 Appadurai, Arjun, "Introduction: Commodities and the Politics of Value,”in : The Social Life of Things" Cambridge University Press 3-63, 1986

    26 Santoro, Michael A., "Introduction: Charting a Sustainable Path for the Twenty-First Century Pharmaceutical Industry,”in : Ethics and the Pharmaceutical Industry" Cambridge University Press 1-8, 2005

    27 Werhane, Patricia H, "Intellectual Property Rights, Access to Life-Enhancing Drugs, and Corporate Moral Responsibilities,”in : Ethics and the Pharmaceutical Industry" Cambridge Unive 2005

    28 Collier, Stephen J, "Global Assemblages, Anthropological Problems" Blackwell Publishing 3-22, 2005

    29 Robins, Steven, "From the Rights to Ritual: Aids Activism in South Africa" 108 (108): 312-323, 2006

    30 Ministry of Public Health and National Health Security Office (약칭 MOPH and NHSO), "Facts and Evidences on the 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand: Document to Support Strengthening"

    31 Tanasugarn, Chanauntong, "Effectiveness of PLWHA Participation Model on ARV Compliance and Quality of Life of PLWHA" Mahidol University

    32 Smith, Raymond A, "Drugs into Bodies" Praeger 2006

    33 Individual Members of the Faculty of Harvard University, "Consensus Statement on Antiretroviral Treatment for Aids in Poor Countries" Harvard School of Pubic Health 2000

    34 Rose, Nikolas, "Biopolitics in the Twenty-First Century" Princeton University Press 9-40, 2006

    35 Nguyen, Vinh-Kim, "Antiretroviral Globalism, Biopolitics, and Therapetutic Citizenship" Blackwell 124-144, 2005

    36 Fordham, Graham, "A New Look at Thai AIDS: Perspectives from the Margin" Berghan Books 2005

    더보기

    동일학술지(권/호) 다른 논문

    동일학술지 더보기

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2027 평가 재인증평가 신청대상 (재인증)
    2021-01-01 등재 등재학술지 유지 (재인증) KCI등재
    2018-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2015-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2011-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2007-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2004-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2003-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2002-01-01 등재 등재후보학술지 유지 (등재후보1차) KCI등재후보
    1999-07-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.78 0.78 0.91
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.96 0.86 1.47 0.14
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼